Avenue Therapeutics (NASDAQ: ATXI) Stock Skyrockets on Positive FDA Developments for IV Tramadol
On Thursday, Avenue Therapeutics (NASDAQ: ATXI) stock surged by almost 96% after the specialty pharmaceutical company secured final approval from […]
Avenue stock